- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04973553
Dose Escalation Upper Limb Rehabilitation in Stroke
Finding the Optimal Session Length of Upper Limb Rehabilitation of People With Moderate to Severe Upper Limb Sensorimotor Impairments After Acute Stroke: A Dose Escalation Study
A phase 1, single-ascending dose clinical trial will be conducted. This study will be designed to test increasing doses of multimodal exercise in successive cohorts of six participants (cumulative 3 + 3 design)[22] (Figure 1).
Maximum dose is reached when two or more participants experience DLT. DLT, dose-limiting tolerance.
The 'dose' will be defined as the ability to reach a fixed maximal level of exercise (type, duration (including session length) in the first two weeks post-stroke without experiencing dose-limiting tolerance (DLT). DLT thresholds will be based on failure to completeshould be less than 80% of prescribed 3-day rehabilitation dose due to pain, rate of perceived exertion, fatigue, or effort required.
Rehabilitation and measurement sessions will be held at either at the Stroke or Geriatric Units at Campus Sint-Jan, Genk or at the rehabilitation unit at Sint-Barbara, Lanaken and Cliniques Saint-Luc with medical services on site. All participants will be monitored for fatigue and pain pre, during and at post-intervention daily. The researchers (PI of project [Dr Peter Hallet, ZOL] Postdoctoral Researcher [Dr Lisa Tedesco Triccas, UHasselt] and PhD/Masters Students [UHasselt) will conduct the clinical tests and will conduct the rehabilitation program.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Genk, Belgium, 3600
- Ziekenhuis Oost-Limburg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- a first-ever unilateral, diagnosed stroke by a neurologist as defined by the World Health Organisation,
- been admitted to the acute hospital for rehabilitation,
- UL hemiparesis or hemiplegia with a ≥ trace of muscle contraction (≥grade 1 at wrist extensors measured by the MRC Scale and severely motor affected by score of 2 or 3 on item number 5 on the NIH Stroke Scale (NIHSS),
- the age of > 18 years and (e) the ability to provide informed consent.
Exclusion Criteria:
- other neurological impairments that could interfere with the protocol such as multiple sclerosis and Parkinson's
- serious communication, cognitive and language deficits which might hamper the assessment (score of >1 on the command item of the NIHSS).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: participants with acute stroke
(a) a first-ever unilateral, diagnosed stroke by a neurologist as defined by the World Health Organisation, (b) been admitted to the acute hospital for rehabilitation, (c) Upper limb hemiparesis or hemiplegia with a trace of muscle contraction:≥grade 1 at shoulder (abductors or elevators) or wrist/finger extensors measured by the MRC Scale and a score of <61 on the Motricity Index and severely motor affected by score of 2 or 3 on item number 5 on the NIH Stroke Scale (NIHSS)[24], (d) the age of > 18 years and (e) the ability to provide informed consent.
|
the intervention consisting of two components: a) Upper limb training protocol; b) Technology-assist training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fugl-Meyer Assessment of Motor Recovery after Stroke
Time Frame: baseline
|
a stroke-specific, performance-based impairment index.The scale is comprised of five domains and there are 155 items in total (motor functioning, sensory functioning, balance, joint range motion, joint pain).
Scoring is based on direct observation of performance.
Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully.
The total possible scale score is 226.
|
baseline
|
|
Fugl-Meyer Assessment of Motor Recovery after Stroke
Time Frame: day 6
|
a stroke-specific, performance-based impairment index.The scale is comprised of five domains and there are 155 items in total (motor functioning, sensory functioning, balance, joint range motion, joint pain).
Scoring is based on direct observation of performance.
Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully.
The total possible scale score is 226.
|
day 6
|
|
Fugl-Meyer Assessment of Motor Recovery after Stroke
Time Frame: day 9
|
a stroke-specific, performance-based impairment index.The scale is comprised of five domains and there are 155 items in total (motor functioning, sensory functioning, balance, joint range motion, joint pain).
Scoring is based on direct observation of performance.
Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully.
The total possible scale score is 226.
|
day 9
|
|
Fugl-Meyer Assessment of Motor Recovery after Stroke
Time Frame: day 12
|
a stroke-specific, performance-based impairment index.The scale is comprised of five domains and there are 155 items in total (motor functioning, sensory functioning, balance, joint range motion, joint pain).
Scoring is based on direct observation of performance.
Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully.
The total possible scale score is 226.
|
day 12
|
|
Fugl-Meyer Assessment of Motor Recovery after Stroke
Time Frame: day 15
|
a stroke-specific, performance-based impairment index.The scale is comprised of five domains and there are 155 items in total (motor functioning, sensory functioning, balance, joint range motion, joint pain).
Scoring is based on direct observation of performance.
Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully.
The total possible scale score is 226.
|
day 15
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motricity index
Time Frame: day 3
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 3
|
|
Motricity index
Time Frame: day 4
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 4
|
|
Motricity index
Time Frame: day 5
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 5
|
|
Motricity index
Time Frame: day 6
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 6
|
|
Motricity index
Time Frame: day 7
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 7
|
|
Motricity index
Time Frame: day 8
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 8
|
|
Motricity index
Time Frame: day 9
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 9
|
|
Motricity index
Time Frame: day 10
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 10
|
|
Motricity index
Time Frame: day 11
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 11
|
|
Motricity index
Time Frame: day 12
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 12
|
|
Motricity index
Time Frame: day 13
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 13
|
|
Motricity index
Time Frame: day 14
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 14
|
|
Motricity index
Time Frame: day 15
|
Measurement of upper limb strength.
The weighted score based on the ordinal 6 point scale of Medical Research Council was used to measure maximal isometric muscle strength.
|
day 15
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 3
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 3
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 4
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 4
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 5
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 5
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 6
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 6
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 7
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 7
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 8
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 8
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 9
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 9
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 10
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 10
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 11
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 11
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 12
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 12
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 13
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 13
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 14
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 14
|
|
Visual Analog Scale of Fatigue (VAS-f)
Time Frame: day 15
|
The scale consists of 18 items relating to the subjective experience of fatigue.Each line is 100 mm in length - thus, scores fall between 0 and 100.
The instrument also possesses two subscales: fatigue (items 1-5 and 11-18) and energy (items 6-10).
|
day 15
|
|
Borg RPE Scale
Time Frame: day 3
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 3
|
|
Borg RPE Scale
Time Frame: day 4
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 4
|
|
Borg RPE Scale
Time Frame: day 5
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 5
|
|
Borg RPE Scale
Time Frame: day 6
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 6
|
|
Borg RPE Scale
Time Frame: day 7
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 7
|
|
Borg RPE Scale
Time Frame: day 8
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 8
|
|
Borg RPE Scale
Time Frame: day 9
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 9
|
|
Borg RPE Scale
Time Frame: day 10
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 10
|
|
Borg RPE Scale
Time Frame: day 11
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 11
|
|
Borg RPE Scale
Time Frame: day 12
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 12
|
|
Borg RPE Scale
Time Frame: day 13
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 13
|
|
Borg RPE Scale
Time Frame: day 14
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 14
|
|
Borg RPE Scale
Time Frame: day 15
|
Measurement of physical activity intensity (6 to 20 scale)
|
day 15
|
|
Numeric rating scale pain
Time Frame: day 3
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 3
|
|
Numeric rating scale pain
Time Frame: day 4
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 4
|
|
Numeric rating scale pain
Time Frame: day 5
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 5
|
|
Numeric rating scale pain
Time Frame: day 6
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 6
|
|
Numeric rating scale pain
Time Frame: day 7
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 7
|
|
Numeric rating scale pain
Time Frame: day 8
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 8
|
|
Numeric rating scale pain
Time Frame: day 9
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 9
|
|
Numeric rating scale pain
Time Frame: day 10
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 10
|
|
Numeric rating scale pain
Time Frame: day 11
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 11
|
|
Numeric rating scale pain
Time Frame: day 12
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 12
|
|
Numeric rating scale pain
Time Frame: day 13
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 13
|
|
Numeric rating scale pain
Time Frame: day 14
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 14
|
|
Numeric rating scale pain
Time Frame: day 15
|
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable")
|
day 15
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Lisa Tabone, dr., Hasselt University
- Principal Investigator: Peter Feys, prof. dr., Hasselt University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DOMINO-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on upper limb rehabilitation
-
Glasgow Caledonian UniversityCompletedSpinal Cord Injuries | Upper Extremity Paralysis | TetraplegiaUnited Kingdom
-
D'Or Institute for Research and EducationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsUnknown
-
IRCCS San Raffaele RomaUniversità degli Studi di Ferrara; I.R.C.C.S. Fondazione Santa Lucia; Ministry... and other collaboratorsActive, not recruitingStroke | Upper Extremity ParesisItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; IRCCS Centro Neurolesi Bonino PulejoRecruiting
-
Fondazione Italiana Sclerosi MultiplaUniversita degli Studi di GenovaCompletedMultiple Sclerosis
-
Fondazione Don Carlo Gnocchi OnlusIstituto Di Ricerche Farmacologiche Mario NegriCompleted
-
National Taiwan University HospitalRecruitingStroke | RehabilitationTaiwan
-
DigitalRehabNot yet recruitingProstheses | Adhesive Capsulitis, Shoulder | Shoulder Posterior Instability | Shoulder Anterior Instability | Shoulder Anterior Latarjet InstabilityItaly
-
The Hong Kong Polytechnic UniversityRecruiting
-
Istituto di Sistemi e Tecnologie Industriali Intelligenti...IRCCS Eugenio Medea; Fondazione Don Carlo Gnocchi Onlus; IRCCS Fondazione Stella... and other collaboratorsRecruitingCongenital and Acquired Neuromotor Disorders | Developmental Coordination Disorder (DCD)Italy